相关实验视频

Updated: Jul 5, 2025

Characterization and Functional Prediction of Bacteria in Ovarian Tissues

Characterization and Functional Prediction of Bacteria in Ovarian Tissues

Published on: October 23, 2021

637个人类代谢物与卵巢癌之间的因果关系:一项门德尔的随机化研究

Yedong Huang^1,2,3, Wenyu Lin^1,4, Xiangqin Zheng^5,6,7

¹College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.

|January 23, 2024

概括

这项研究使用了门德尔的随机化来确定代谢物和卵巢癌 (OC) 之间的因果关系. 发现几种代谢物可以促进或抑制OC的发展,表明它们作为生物标志物的潜力.

科学领域:

代谢学代谢学代谢学
遗传学遗传学是一个
在瘤学瘤学.

背景情况:

已知代谢物和卵巢癌 (OC) 之间的关联,但因果关系尚不清楚.
门德尔随机化 (MR) 是研究因果关系的合适方法.
这项研究旨在澄清代谢物和OC之间的因果关系.

研究的目的:

使用孟德尔随机化研究各种代谢物对卵巢癌 (OC) 的因果关系.
为了确定可能促进或抑制OC发展的特定代谢物.
探索这些代谢物的潜力,作为OC的诊断或预后生物标志物.

主要方法:

利用一个大规模的基因组广泛关联研究 (GWAS) 数据库,对637种代谢物 (暴露) 和OC (结果) 进行了分析.
采用孟德尔随机化 (MR) 分析与逆方差加权 (IVW),MR-Egger和加权中位数 (WM) 方法.
应用了施泰格的上游测试,以确认因果方向,并评估潜在的偏差,如异质性和水平向性.

主要成果:

确定了31种对OC具有显著因果作用的代谢物 (P < 0.05).
通过施泰格测试确认了9种具有稳定的因果作用的代谢物.
发现某些代谢物 (例如,安德罗斯特硫酸盐,VLDL脂质) 促进OC,而其他代谢物 (例如,八甲尼丁,N2,N2-二甲基瓜诺辛) 抑制它.

结论:

门德尔的随机化揭示了代谢物对卵巢癌的复杂因果关系.
特定的代谢产物显示出作为OC的有前途的生物标志物的潜力.
需要对这些已识别的代谢物进行进一步的临床验证.

关键词:

随机效应是一种随机效应.门德尔的随机化它的代谢物是代谢物.卵巢癌是发生在卵巢中的癌症.

更多相关视频

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry

Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry

Published on: April 3, 2019

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Nondisjunction

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...